SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001935979-23-000049
Filing Date
2023-07-31
Accepted
2023-07-31 16:29:43
Documents
13
Period of Report
2023-07-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20230731.htm   iXBRL 8-K 24381
2 EX-99.1 a2023q2bhvnltdearningsprex.htm EX-99.1 150828
  Complete submission text file 0001935979-23-000049.txt   322015

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20230731.xsd EX-101.SCH 1922
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20230731_lab.xml EX-101.LAB 24801
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20230731_pre.xml EX-101.PRE 13045
7 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20230731_htm.xml XML 2802
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41477 | Film No.: 231127727
SIC: 2834 Pharmaceutical Preparations